Lead Product(s) : Insulin Lispro
Therapeutic Area : Endocrinology
Study Phase : Approved FDF
Sponsor : Biocon
Deal Size : Inapplicable
Deal Type : Inapplicable
Biocon Biologics’ Partner Receives Approval for Human Insulin for IV Infusion
Details : Inpremzia is an approved medicine used to treat people with diabetes who need insulin to keep their blood glucose (sugar) level controlled. It contains the active substance insulin human.
Product Name : Inpremzia
Product Type : Peptide
Upfront Cash : Inapplicable
April 01, 2022
Lead Product(s) : Insulin Lispro
Therapeutic Area : Endocrinology
Highest Development Status : Approved FDF
Sponsor : Biocon
Deal Size : Inapplicable
Deal Type : Inapplicable